![](/img/cover-not-exists.png)
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Harrison, Claire, Kiladjian, Jean-Jacques, Al-Ali, Haifa Kathrin, Gisslinger, Heinz, Waltzman, Roger, Stalbovskaya, Viktoriya, McQuitty, Mari, Hunter, Deborah S., Levy, Richard, Knoops, Laurent, CervaVolume:
366
Language:
english
Journal:
New England Journal of Medicine
DOI:
10.1056/nejmoa1110556
Date:
March, 2012
File:
PDF, 641 KB
english, 2012